Structure via PubChem · Public domain (PubChem)
sulfasalazine
Sign in to saveAlso known as Azulfidine®, Salazopyridin®, Salazopyrin®, SAS-500, Salicylazosulfapyridine, Salazosulfapyridine, 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid, 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid
Sulfasalazine, sold under the brand name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It is considered by some to be a first-line treatment in rheumatoid arthritis. It is taken by mouth or can be administered rectally.
In the Vinony graph
Within Vinony's link graph, sulfasalazine is referenced by 249 other articles, and connects out to kidney failure, World Health Organization Model List of Essential Medicines and sulfonamide drug.
Vinony files it under 2-Pyridyl compounds, Azo compounds and Codrugs.
Its subject is documented across 34 Wikipedia language editions.
Chemical data
- Formula
- C18H14N4O5S
- Molecular weight
- 398.4 g/mol
- IUPAC name
- (3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid
- SMILES
- C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C/3\C=CC(=O)C(=C3)C(=O)O
- InChIKey
- OQANPHBRHBJGNZ-FYJGNVAPSA-N
- XLogP
- 2.3
- Polar surface area
- 146 Ų
- H-bond donors
- 3
- H-bond acceptors
- 9
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1950
- Admin. routes
- oral
- Indications
- ankylosing spondylitis, neuropathy, rheumatoid arthritis, osteomyelitis
via ChEMBL · EBI
Research
7,370 papers- [Sulfasalazine therapy in spondylarthritis ankylopoietica].Orvosi hetilap · 1989
- Evolution of olsalazine.Scandinavian journal of gastroenterology. Supplement · 1988
- [New and old therapeutic options in ankylosing spondylitis--is there an indication for sulfasalazine?].Zeitschrift fur Rheumatologie · 2002
- [Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid].Klinische Wochenschrift · 1988
- [Mode of action of sulfasalazine in chronic inflammatory enterocolonic diseases].Therapie · 1992
via PubMed
Wikidata facts
- Has part
- carbon
- Mass
- 398.0685
- Has use
- medication
Show 8 more facts
- chemical formula
- C₁₈H₁₄N₄O₅S
- medical condition treated
- arthritis
- World Health Organisation international non-proprietary name
- sulfasalazin
- isomeric SMILES
- C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)/N=N/C3=CC=C(C(=C3)C(=O)O)O
- canonical SMILES
- C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC=C(C(=C3)C(=O)O)O
- Commons category
- Sulfasalazine
- subject has role
- essential medicine
- stylized name
- sulfaSALAzine
via Wikidata · CC0
~6 min read
Encyclopedic overview
7 sectionsContents
- Medical uses
- Side effects
- Pharmacology
- Chemistry
- Cost
- Research
- References
{{Drugbox | Verifiedfields = changed | verifiedrevid = 460764435 | image = Sulfasalazine.svg | image_class = skin-invert-image | alt =
| tradename = Azulfidine, Salazopyrin, Sulazine, others | Drugs.com = | MedlinePlus = a682204 | DailyMedID = Sulfasalazine | pregnancy_AU = A | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = By mouth | class = Sulfonamides | ATC_prefix = A07 | ATC_suffix = EC01
Excerpted from Wikipedia’s “sulfasalazine” article, available under the CC BY-SA 4.0 licence.